Current challenges and next steps in treating pediatric acute respiratory distress syndrome

A new review of Pediatric Acute Respiratory Distress Syndrome (PARDS) highlights the lack of data available for standard treatment approaches and adjunctive therapies, leading to significant variability in patient management. This comprehensive review article, which also identifies a great need for studies to generate outcomes data in pediatric patients with ARDS, is published in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

In “The Current State of Pediatric Acute Respiratory Distress Syndrome” coauthors Kirsten E. Orloff, MD, David A. Turner, MD, FCCM, FCCP, and Kyle J. Rehder, MD, FCCM, FCCP, Duke Children’s Hospital, Durham, NC, present the physiologic basis of PARDS and describe the unique pediatric definition of the disorder and what puts a child at risk. The authors provide a thorough discussion of the current best practice strategies, including lung protective strategies as well as adjunctive options for these critically ill children. In the section entitled “Next Steps,” they call for more high-quality data to support the effectiveness of potential treatments, studies that focus on pediatric patients with severe PARDS, and out-comes data in pediatric survivors of ARDS that would assess its effects on lung function, quality of life, and neurocognitive functioning.

Source: Read Full Article